KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,598.00
-8.00 (-0.50%)
Jan 21, 2026, 3:30 PM JST
KYORIN Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 12,930 | 12,770 | 7,019 | 6,906 | 5,216 | 8,352 | Upgrade |
Depreciation & Amortization | 4,574 | 4,603 | 4,290 | 3,840 | 3,714 | 3,564 | Upgrade |
Loss (Gain) From Sale of Assets | 127 | 127 | 90 | 272 | 32 | -342 | Upgrade |
Loss (Gain) From Sale of Investments | -64 | 305 | -993 | -674 | 320 | -488 | Upgrade |
Loss (Gain) on Equity Investments | -38 | -38 | 12 | - | -25 | -49 | Upgrade |
Other Operating Activities | -3,534 | -1,640 | -3,581 | 1,397 | -1,238 | -1,895 | Upgrade |
Change in Accounts Receivable | -764 | 158 | -439 | -5,621 | -1,226 | 7,001 | Upgrade |
Change in Inventory | -10,076 | -12,330 | -5,444 | -5,809 | -3,633 | -5,284 | Upgrade |
Change in Accounts Payable | 9 | 1,252 | 319 | 3,085 | 3,875 | -2,596 | Upgrade |
Change in Other Net Operating Assets | 3,151 | -1,701 | 276 | -1,388 | -689 | -3,074 | Upgrade |
Operating Cash Flow | 6,315 | 3,506 | 1,549 | 2,008 | 6,346 | 5,189 | Upgrade |
Operating Cash Flow Growth | - | 126.34% | -22.86% | -68.36% | 22.30% | -32.95% | Upgrade |
Capital Expenditures | -2,936 | -5,697 | -5,778 | -6,330 | -2,444 | -4,067 | Upgrade |
Sale of Property, Plant & Equipment | 129 | 42 | - | 100 | - | 368 | Upgrade |
Divestitures | - | - | 921 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -206 | -596 | -468 | -3,075 | -246 | -1,057 | Upgrade |
Investment in Securities | 1,178 | -52 | 2,645 | 3,281 | 317 | 632 | Upgrade |
Other Investing Activities | 193 | -20 | -507 | -251 | -187 | -135 | Upgrade |
Investing Cash Flow | -1,642 | -6,323 | -3,187 | -6,275 | -2,560 | -4,259 | Upgrade |
Long-Term Debt Issued | - | 20,000 | - | - | - | - | Upgrade |
Total Debt Issued | 6,000 | 20,000 | - | - | - | - | Upgrade |
Short-Term Debt Repaid | - | -2,700 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -10,200 | -200 | -200 | -200 | -428 | Upgrade |
Total Debt Repaid | -8,200 | -12,900 | -200 | -200 | -200 | -428 | Upgrade |
Net Debt Issued (Repaid) | -2,200 | 7,100 | -200 | -200 | -200 | -428 | Upgrade |
Common Dividends Paid | -3,302 | -3,015 | -3,013 | -3,015 | -3,767 | -4,347 | Upgrade |
Other Financing Activities | -145 | -133 | -134 | -148 | -145 | -143 | Upgrade |
Financing Cash Flow | -5,647 | 3,952 | -3,347 | -3,363 | -4,112 | -4,918 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | 87 | 241 | 139 | -43 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | -31 | -83 | 1 | -2 | Upgrade |
Net Cash Flow | -974 | 1,135 | -4,929 | -7,472 | -186 | -4,033 | Upgrade |
Free Cash Flow | 3,379 | -2,191 | -4,229 | -4,322 | 3,902 | 1,122 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 247.77% | -78.06% | Upgrade |
Free Cash Flow Margin | 2.53% | -1.68% | -3.54% | -3.82% | 3.70% | 1.09% | Upgrade |
Free Cash Flow Per Share | 58.82 | -38.14 | -73.69 | -75.42 | 68.09 | 19.58 | Upgrade |
Cash Interest Paid | 244 | 173 | 66 | 66 | 66 | 68 | Upgrade |
Cash Income Tax Paid | 3,479 | 1,317 | 2,975 | 2,065 | 1,248 | 1,899 | Upgrade |
Levered Free Cash Flow | 1,236 | -5,979 | -3,378 | -10,346 | 3,176 | -853.13 | Upgrade |
Unlevered Free Cash Flow | 1,388 | -5,871 | -3,336 | -10,304 | 3,218 | -810.63 | Upgrade |
Change in Working Capital | -7,680 | -12,621 | -5,288 | -9,733 | -1,673 | -3,953 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.